Searchable abstracts of presentations at key conferences in endocrinology

ea0056p1100 | Thyroid (non-cancer) | ECE2018

Prevalence of thyroid dysfunction in Catalonia from two different registers: pharmaceutical delivery records and diagnostic records (EUthyroid project)

Torrejon Sara , Soldevila Berta , Martin-Baranera Montse , Puig-Domingo Manel , Velasco Ines , Vila Lluis , Thyroid Area of Spanish Society of Endocrinology and Nutrition

Background: Cross-sectional studies performed to estimate the prevalence (Prev) of thyroid dysfunctions are expensive and involve a great effort. Diagnosis and therapeutic prescription records may be a good alternative to monitor such prevalence. They also allow to easily compare the thyroid dysfunctions prevalence of among different populations (EUthyroid Project).Objective: 1) To estimate the Prev of hypothyroidism (hypoT) and hyperthyroidism (hyperT) ...

ea0081ep776 | Pituitary and Neuroendocrinology | ECE2022

Primary cilia in Pituitary neuroendocrine tumours and their association with aggressiveness

Martinez-Hernandez Rebeca , Serrano-Somavilla Ana , Sampedro-Nunez Miguel , Calatayud Mari a , Vicente Almudena , Garcia-de-Casasola Gonzalo , Sanz-Garcia Ancor , Puig-Domingo Manel , Marazuela Monica

Purpose: Although growing evidence supports the role of primary cilia (PC) in the regulation of cancer development, their possible role has not yet been studied in pituitary neuroendocrine tumours (PitNETs). The study of cilia could serve as a diagnostic tool providing new insights into the mechanisms of tumorigenesis and aggressiveness of PitNETs. Methods: A total of 86 patients with PitNETs (28 functioning and 58 non-functioning [NF-PitNETs]) and 12 co...

ea0049gp84 | Diabetes & complications 2 | ECE2017

Antidiabetic medication use and the risk of fracture in type 2 diabetic patients: a nested case-control study

Losada Eladio , Soldevila Berta , Ali M. Sanni , Martinez-Laguna Daniel , Nogues Xavier , Diez-Perez Adolfo , Puig-Domingo Manel , Mauricio Didac , Prieto-Alhambra Daniel

Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of fragility fractures. Anti-diabetic oral agents and insulin may also impact on fracture risk. There is however scarce data available on the effect of such therapies combined as usually prescribed in real-life practice conditions.Objectives: The objective of this study was to compare the risk of fracture among T2DM patients who are users of different antidiabetic treatments...

ea0070aep729 | Pituitary and Neuroendocrinology | ECE2020

Characterization of epithelial-mesenchymal transition in growth hormone-secreting adenomas

Gil Joan , Marques-Pamies Montserrat , García-Martínez Araceli , Serra Guillermo , Webb Susan , Antonio Sampedro-Nunez Miguel , Pico Antonio , Marazuela Monica , Jorda Mireia , Puig-Domingo Manel

First generation somatostatin receptor ligands (SRL) are the first-line drugs in primary acromegaly treatment or after surgical failure in patients with active acromegaly. In previous studies we confirmed the association of the expression of SSTR2, Ki67 and E-cadherin (CDH1) in responsive GH-secreting adenomas response to SRL. Moreover, E-cadherin showed a greater predictive capacity than most of the markers described. Loss of E-cadherin is a typical mark of ...

ea0056gp101 | Diabetes Therapy | ECE2018

A healthier fat intake is associated with absence of diabetic retinopathy in patients with type 1 diabetes

Granado-Casas Minerva , Martin Mariona , Real Jordi , Ramirez-Morros Anna , Castelblanco Esmeralda , Alonso Nuria , Traveset Alicia , Alcubierre Nuria , Puig-Domingo Manel , Hernandez Marta , Mauricio Didac

Background: Medical nutrition therapy is an important part of the management of type 1 diabetes mellitus (T1DM). Proper adherence to a healthy diet may have a favorable impact on diabetic complications. Our aim was to assess differences in food and nutrient intake of type 1 diabetic patients with and without diabetic retinopathy (DR).Subjects and methods: This was a two-center, cross-sectional study in patients diagnosed with T1DM with and without DR. Su...

ea0056gp207 | Pituitary Clinical | ECE2018

Molecular profiling of non-functioning pituitary adenomas does not support pharmacological therapeutic options

Gil Joan , Blanco Alberto , Serra Guillermo , Salinas Isabel , Webb Susan M , Hostalot Cristina , Obiols Gabriel , Valassi Elena , Roig Olga , Sesmilo Gemma , Villabona Carles , Jorda Mireia , Puig-Domingo Manel

Non-functioning pituitary adenomas (NFPA) are the most common pituitary tumours. They usually come to medical attention because of a mass effect and/or hypopituitarism. Tumour shrinkage during therapy with either dopamine agonists (DA) or somatostatin analogues (SSA) has been previously reported in some cases; however, response of NFPA to medical treatment is still poor and unpredictable. Our aim was to explore the molecular mechanisms underlying this lack of efficacy through ...

ea0056gp257 | Thyroid non cancer - Autoimmune Thyroid disease/pregnancy | ECE2018

Impact of TSH during the first trimester of pregnancy in obstetric and fetal complications: Usefulness of 2.5 mIU/l cut-off value

Soldevila Berta , Hernandez Marta , Lopez Carolina , Cacenarro Laura , Martinez-Barahona Maria , Palomera Elisabet , Rius Ferran , Lecube Albert , Pelegay Maria Jose , Garcia Jordi , Mauricio Didac , Puig-Domingo Manel

Background: An association of pregnancy outcomes with subclinical hypothyroidism have been reported, however, there still exists a strong controversy regarding whether subclinical hypothyroidism ought to be dealt with or not. The latest American Thyroid Association’s guideline gives support to a higher TSH upper reference range of 4 mIU/l than the one proposed a few years ago of 2.5 mIU/l for the first trimester of pregnancy, in the absence of local normal ranges of TSH. ...

ea0035p722 | Neuroendocrinology | ECE2014

Long-term remission and recurrence rate in a cohort of Cushing's disease: The need for long-term follow-up

Velazquez Gloria B. Aranda , Hanzu Felicia A. , Porta Mireia Mora , Ensenat Joaquin , Puig-Domingo Manel , Osaba Maria Jesus Martinez de , Casals Gregori , Verger Eugenia , Ribalta Maria Teresa , Patrascioiu Ioana , Halperin Irene

Introduction: Transsphenoidal surgery (TSS) is the procedure of choice in Cushing disease (CD), with immediate post-operative remission rates ranging between 59 and 94% and recurrence rates between 3 and 46%, both depending upon the definition criteria and the duration of the follow-up. Our aim was to assess the rate of remission, recurrence and persistence of the disease after the first treatment and to identify predictors of remission in the CD population of our center durin...

ea0056oc9.4 | Thyroid from basics to clinics | ECE2018

Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer

Rodriguez Helena , Zafon Carles , Villalmanzo Nuria , Cerda Lorena , Iglesias Carmela , Real Jordi , Gil Joan , Hesselink Esther N. Klein , van Hemel Bettien M. , Montero-Conde Cristina , Reverter Jordi L. , Mauricio Didac , Puig-Domingo Manel , Robledo Mercedes , Links Thera P. , Jorda Mireia

Background: Differentiated thyroid cancer (DTC) is usually associated with an excellent prognosis. The main cause of death is due to distant metastases, but distant metastatic DTC (dmDTC) presents an interpatient heterogeneity. Some patients with distant metastases live with stable disease for many years, while others die very early. Still no effective biomarkers are available to predict either which patients will eventually develop distant metastases or what will be the final...

ea0056gp116 | Diabetes Translational | ECE2018

The role of oncostatin m in the development of type 2 diabetes associated with obesity

Taxeras Siri , Piquer-Garcia Irene , Pellitero Silvia , Puig Rocio , Martinez Eva , Tarasco Jordi , Moreno Pau , Bombuy Ernest , Higueras Carmen , Malagon Paloma , Lerin Carles , Puig-Domingo Manel , Sanchez-Infantes David

Background: Obesity can lead type 2 diabetes (T2D), however there are patients with obesity who present euglycemia. The mechanisms by which T2D appears have not been fully elucidated. Oncostatin m (OSM) is a proinflammatory cytokine, member of the IL-6 family, which is increased in obesity in mice and humans, and impairs browning in mice. Here, we aim at evaluating the potential role of OSM in the development of T2D in patients with obesity.Material and ...